|
SGK3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20689999996804E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53669998947947E-09 |
| Normal-vs-Stage2 |
8.610500E-04 |
| Normal-vs-Stage3 |
5.1735999995195E-07 |
| Normal-vs-Stage4 |
8.798600E-04 |
| Stage1-vs-Stage2 |
1.977570E-01 |
| Stage1-vs-Stage3 |
4.253600E-01 |
| Stage1-vs-Stage4 |
6.144200E-01 |
| Stage2-vs-Stage3 |
4.170000E-02 |
| Stage2-vs-Stage4 |
1.455760E-01 |
| Stage3-vs-Stage4 |
8.355000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.3647000000061E-06 |
| Normal-vs-AfricanAmerican |
1.61789999999495E-05 |
| Normal-vs-Asian |
1.611690E-02 |
| Caucasian-vs-AfricanAmerican |
5.873000E-01 |
| Caucasian-vs-Asian |
9.165400E-01 |
| AfricanAmerican-vs-Asian |
7.577400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.83809999998452E-06 |
| Normal-vs-Female |
7.18310000036304E-07 |
| Male-vs-Female |
6.301600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.82470000015856E-07 |
| Normal-vs-Extreme_Weight |
5.17559999968498E-07 |
| Normal-vs-Obese |
2.41309999999828E-05 |
| Normal-vs-Extreme_Obese |
1.037050E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.019600E-01 |
| Normal_Weight-vs-Obese |
3.011800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.578000E-01 |
| Extreme_Weight-vs-Obese |
1.431850E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.733400E-01 |
| Obese-vs-Extreme_Obese |
4.399000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.463000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.60560000001175E-06 |
| Normal-vs-Age(61-80Yrs) |
8.95860052807507E-10 |
| Normal-vs-Age(81-100Yrs) |
6.822900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.542800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.269600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.640400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.057400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.092000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.564400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.24360000034407E-07 |
| Normal-VS-Type2 PRCC |
3.967400E-04 |
| Normal-VS-KIRP CIMP |
2.91119999995537E-07 |
| Normal-VS-Unclassified PRCC |
7.5837000000023E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.086200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.182430E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.218180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.780000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.464400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.500500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.89810000003921E-06 |
| Normal-vs-N1 |
1.53373999999262E-05 |
| Normal-vs-N2 |
2.401200E-03 |
| N0-vs-N1 |
6.276200E-01 |
| N0-vs-N2 |
7.347900E-02 |
| N1-vs-N2 |
3.548000E-02 |
|
|
